caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760596357

Amal Shibli RahhalMD

PRACTICEUIHC UROLOGY CLINICSee all providers at this practice →
EndocrinologyIowa City, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Amal Shibli Rahhal's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
STATE UNIVERSITY OF IOWA231753
Donald Brown
Internal Medicine · Iowa City, IA
4293
Brian Mullan
Diagnostic Radiology · Iowa City, IA
2550
NPI 14775387672332
SOUTHEAST IOWA REGIONAL MEDICAL CENTER, INC.2382
NPI 10139068901828
Michael Giudici
Clinical Cardiac Electrophysiology · Mason City, IA
1423
Jack Kademian
Diagnostic Radiology · Iowa City, IA
1323
Robert Weiss
Cardiology · Iowa City, IA
1317
NOLAN, SARAH1221
DOELLE, GREGORY1220
HENRY COUNTY SOLDIERS' AND SAILORS' MEMORIAL HOSPITAL1130
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
162
Beneficiaries
—
Total drug cost
$438K
Distinct drugs
5
Brand share
7.4%
Top prescribed drugs
Alendronate Sodium97 claims
Levothyroxine Sodium21 claims
Teriparatide17 claims
Risedronate Sodium15 claims
Burosumab-Twza12 claims
QUALITY · MIPS · 2024
Final MIPS score
80.0
Quality
75.7
Cost
72.3
Improvement activities
40.0
Promoting interop.
78.0
Payment adjustment
0.21%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
243
Unique beneficiaries
—
Total services
243
Distinct HCPCS
4
Medicare payment
$12K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 36 Endocrinology providers in IA — below median (cohort median 639).